Skip to content

Evaluation of a collaborative smoking cessation intervention

Evaluation of a collaborative smoking cessation intervention - ENTER

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00006079
Enrollment
720
Registered
2014-06-04
Start date
2014-06-30
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F17 J44 I00-I99

Interventions

Group 1: Doctors ask patients about their tobacco consumption, motivate them to participate in a smoking cessation program and follow-up on the patients smoking behaviour during subsequent consultatio

Sponsors

Director - Department of Medical Psychology, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - 18 years or older - health insured by AOK - heavy smoker (20 cigarettes per day or more) or suffering from chronic obstructive pulmonary disease (COPD)/ cardiovascular disease and smoker

Exclusion criteria

Exclusion criteria: - younger than 18 years - non-smoker - illiterate - cognitive impairments

Design outcomes

Primary

MeasureTime frame
The primary outcome is that 12 months after the initial consultation with their doctors, the amount of cigarettes smoked per day by patients in the experimental condition is lower than the amount of cigarettes smoked per day by patients in the control condition. Smoking status is assessed with a questionnaire that participants fill in upon inclusion into the study in the general practice. Follow-up takes place via telephone after 3 and 12 months. Cigarette consumption is measured with Menge-Frequenz-Index (Kraus & Augustin, 2005).

Secondary

MeasureTime frame
Secondary outcomes are related to Quality of Life and general well-being. Baseline assessment takes place with a questionnaire that participants fill in upon inclusion into the study in the general practice. Follow-up takes place via telephone after 3 and 12 months. The questionnaire includes items from the Fagerström Test for Nicotine Dependence (Heatherton, Kozlowski, Frecker & Fagerström, 1991), Menge-Frequenz Index (Kraus & Augustin, 2005), SmoCess-GP (Jung et al., 2008), Fragebogen zur Änderungsbereitschaft bei Rauchern (Hannöver et al., 2002), SF-12 (Ware, Kosinski & Keller, 1996), EQ-5D-3L (EuroQol Group, 1990) and Visual Simplified Respiratory Questionnaire (Perez et al., 2009). Moreover, general practitioners document the patient's health status (e.g. severity of the chronic obstructive pulmonary disease or cardiovascular disease) on a form during consultations with patients.

Countries

Germany

Contacts

Public ContactAnna Levke Brütt

University Medical Center Hamburg-Eppendorf, Center for Psychosocial Medicine, Department of Medical Psychology

a.bruett@uke.uni-hamburg.de+49(0)40/7410-57313

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 15, 2026